Norton Rose Fulbright has been hit with indemnity costs in a long-running case brought by a former partner, with a judge finding the law firm persisted with its “continued maintenance of groundless denials” in the lead-up to a $160,000 judgment against it.
The ACCC has raised preliminary competition concerns about Woolworths proposed 65 per cent acquisition of food wholesale distributor PFD Food Services, saying the deal would give Woolworths more power in its dealings with food manufacturers.
A judge has appointed a provisional liquidator to a company owned by missing Sydney businesswoman Melissa Caddick, while criticising ASIC for not cooperating with her brother who is seeking to vary asset preservation orders made over his sister’s property.
The Australian Competition and Consumer Commission has taken franchise giant Retail Food Group to court for allegedly misleading purchasers of loss-making franchises about the profitability or viability of its stores.
A partner bringing a $3.8 million age discrimination lawsuit against Deloitte Touche Tohmatsu will not seek to replead claims struck out earlier this month that the accounting giant made misrepresentations to Rio Tinto.
The Federal Court judge who is now overseeing a high stakes criminal cartel case against several investment banks and individuals over a $2.5 billion ANZ share placement has ordered that an indictment be filed by February 1, telling the parties “we have to get this case moving” and that he hoped to move the matter to trial “before we all retire”.
Arnold Bloch Leibler has hit back at a class action by Slater & Gordon shareholders accusing it of misleading and deceptive conduct and breaching its duty of care by greenlighting the law firm’s $1.2 billion acquisition of Quindell, filing cross-claims against Slater & Gordon and two of its former directors.
BHP Group Ltd has appealed a ruling allowing foreign group members to be part of a shareholder class action against the mining giant over the Fundao dam failure in Brazil five years ago.
Two units of US drug giant Johnson & Johnson have filed a lawsuit seeking preliminary discovery from Juno Pharmaceuticals for a possible patent lawsuit over a popular chemotherapy drug used to treat blood cancer.
Neurim Pharmaceuticals can seek limited additional damages in a patent infringement case relating to its insomnia drug Circadin, after a judge granted a mid-trial bid to amend its pleadings against Generic Partners and Apotex.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
